日本生物材料市场报告（按类型（天然生物材料、金属生物材料、陶瓷生物材料、聚合物生物材料）、应用（神经科、心臟科、骨科、伤口护理、牙科、整形外科及其他）和地区划分，2026-2034）

2025年，日本生物材料市场规模达83.53亿美元。展望未来， IMARC Group预计到2034年，该市场规模将达到220.702亿美元，2026年至2034年期间的复合年增长率（CAGR）为11.40%。心血管疾病、糖尿病和骨科疾病等慢性病病例的增加，以及对生物材料医疗器材和疗法的需求不断增长，是推动市场成长的主要因素。

本报告解答的关键问题：

• 日本生物材料市场目前表现如何？未来几年又将如何发展？
• 新冠疫情对日本生物材料市场产生了哪些影响？
• 日本生物材料市场按类型分類的组成是怎样的？
• 日本生物材料市场依应用领域分類的组成是怎样的？
• 日本生物材料市场价值链的各个阶段有哪些？
• 日本生物材料领域的主要驱动因素和挑战是什么？
• 日本生物材料市场的结构是怎么样的？主要参与者有哪些？
• 日本生物材料市场的竞争程度如何？

目录

第一章：序言

第二章：范围与方法

• 研究目标
• 利害关係人
• 数据来源
• 市场估算
• 预测方法

第三章：执行概要

第四章：日本生物材料市场－简介

• 概述
• 市场动态
• 产业趋势
• 竞争情报

第五章：日本生物材料市场概况

• 历史及当前市场趋势（2020-2025）
• 市场预测（2026-2034）

第六章：日本生物材料市场－按类型划分

• 天然生物材料
• 金属生物材料
• 陶瓷生物材料
• 聚合物生物材料

第七章：日本生物材料市场－依应用领域划分

• 神经病学
• 心臟病学
• 骨科
• 伤口护理
• 牙科
• 整型手术
• 其他的

第八章：日本生物材料市场－按地区划分

• 关东地区
• 关西/近畿地区
• 中部/中部地区
• 九州·冲绳地区
• 东北部地区
• 中国地区
• 北海道地区
• 四国地区

第九章：日本生物材料市场－竞争格局

• 概述
• 市场结构
• 市场参与者定位
• 最佳制胜策略
• 竞争格局分析
• 公司评估象限

第十章：关键参与者简介

第十一章：日本生物材料市场－产业分析

• 驱动因素、限制因素和机会
• 波特五力分析
• 价值链分析

第十二章：附录

Japan biomaterials market size reached USD 8,353.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 22,070.2 Million by 2034, exhibiting a growth rate (CAGR) of 11.40% during 2026-2034. The rising cases of chronic ailments, such as cardiovascular diseases, diabetes, and orthopedic disorders, and the increasing need for biomaterial-based medical devices and therapies, are primarily driving the market.

Biomaterials are substances designed and engineered to interact with biological systems, often for medical or therapeutic purposes. These materials are used in a variety of applications, from artificial organs and tissue engineering to drug delivery systems and medical implants. Biomaterials can be natural, synthetic, or a combination of both, and they are carefully selected based on their compatibility with the human body. Natural biomaterials, such as collagen and silk, are derived from biological sources and are known for their biocompatibility. Synthetic biomaterials, like polymers and ceramics, are tailored for specific properties like strength and durability. The choice of biomaterial depends on the intended function and location within the body. Biomaterials play a crucial role in modern medicine, enabling advancements in treatments and procedures. They can promote tissue regeneration, provide structural support, and serve as carriers for therapeutic agents. However, ensuring their safety and effectiveness is paramount, as they must not elicit harmful immune responses or adverse reactions when introduced into the body. Researchers continually innovate in the field of biomaterials to enhance medical treatments and improve patient outcomes.

Japan Biomaterials Market Trends:

The biomaterials market in Japan is witnessing robust growth, primarily driven by several interconnected factors. Firstly, the increasing cases of chronic diseases such as cardiovascular disorders and orthopedic ailments have propelled the demand for biomaterials in the medical field. Furthermore, an aging regional population is contributing to this trend, as older individuals require more medical interventions that often involve biomaterials. Secondly, technological advancements have significantly enhanced the versatility and effectiveness of biomaterials. This is exemplified by the development of bioactive ceramics, biodegradable polymers, and tissue engineering techniques, which have expanded the scope of biomaterial applications. Thirdly, the growing awareness of the environmental impact of traditional materials has led to a surge in demand for sustainable biomaterials. As consumers become more eco-conscious, biomaterials made from renewable sources, like plant-based polymers, gain traction in various industries, including packaging and automotive. Lastly, numerous government initiatives and regulations that are promoting the use of biomaterials for medical and industrial purposes, are expected to drive the biomaterials market in Japan during the forecast period.

Japan Biomaterials Market Segmentation:

Type Insights:

• Natural Biomaterial
• Metallic Biomaterial
• Ceramic Biomaterial
• Polymeric Biomaterial

Application Insights:

• Neurology
• Cardiology
• Orthopedics
• Wound Care
• Dental
• Plastic Surgery
• Others
• A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes neurology, cardiology, orthopedics, wound care, dental, plastic surgery, and others.

Regional Insights:

• Kanto Region
• Kansai/Kinki Region
• Central/ Chubu Region
• Kyushu-Okinawa Region
• Tohoku Region
• Chugoku Region
• Hokkaido Region
• Shikoku Region
• The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan biomaterials market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan biomaterials market?
• What is the breakup of the Japan biomaterials market on the basis of type?
• What is the breakup of the Japan biomaterials market on the basis of application?
• What are the various stages in the value chain of the Japan biomaterials market?
• What are the key driving factors and challenges in the Japan biomaterials?
• What is the structure of the Japan biomaterials market and who are the key players?
• What is the degree of competition in the Japan biomaterials market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Biomaterials Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Biomaterials Market Landscape

• 5.1 Historical and Current Market Trends (2020-2025)
• 5.2 Market Forecast (2026-2034)

6 Japan Biomaterials Market - Breakup by Type

• 6.1 Natural Biomaterial
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2020-2025)
  • 6.1.3 Market Forecast (2026-2034)
• 6.2 Metallic Biomaterial
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2020-2025)
  • 6.2.3 Market Forecast (2026-2034)
• 6.3 Ceramic Biomaterial
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2020-2025)
  • 6.3.3 Market Forecast (2026-2034)
• 6.4 Polymeric Biomaterial
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2020-2025)
  • 6.4.3 Market Forecast (2026-2034)

7 Japan Biomaterials Market - Breakup by Application

• 7.1 Neurology
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2020-2025)
  • 7.1.3 Market Forecast (2026-2034)
• 7.2 Cardiology
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2020-2025)
  • 7.2.3 Market Forecast (2026-2034)
• 7.3 Orthopedics
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2020-2025)
  • 7.3.3 Market Forecast (2026-2034)
• 7.4 Wound Care
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2020-2025)
  • 7.4.3 Market Forecast (2026-2034)
• 7.5 Dental
  • 7.5.1 Overview
  • 7.5.2 Historical and Current Market Trends (2020-2025)
  • 7.5.3 Market Forecast (2026-2034)
• 7.6 Plastic Surgery
  • 7.6.1 Overview
  • 7.6.2 Historical and Current Market Trends (2020-2025)
  • 7.6.3 Market Forecast (2026-2034)
• 7.7 Others
  • 7.7.1 Historical and Current Market Trends (2020-2025)
  • 7.7.2 Market Forecast (2026-2034)

8 Japan Biomaterials Market - Breakup by Region

• 8.1 Kanto Region
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2020-2025)
  • 8.1.3 Market Breakup by Type
  • 8.1.4 Market Breakup by Application
  • 8.1.5 Key Players
  • 8.1.6 Market Forecast (2026-2034)
• 8.2 Kansai/Kinki Region
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2020-2025)
  • 8.2.3 Market Breakup by Type
  • 8.2.4 Market Breakup by Application
  • 8.2.5 Key Players
  • 8.2.6 Market Forecast (2026-2034)
• 8.3 Central/ Chubu Region
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2020-2025)
  • 8.3.3 Market Breakup by Type
  • 8.3.4 Market Breakup by Application
  • 8.3.5 Key Players
  • 8.3.6 Market Forecast (2026-2034)
• 8.4 Kyushu-Okinawa Region
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2020-2025)
  • 8.4.3 Market Breakup by Type
  • 8.4.4 Market Breakup by Application
  • 8.4.5 Key Players
  • 8.4.6 Market Forecast (2026-2034)
• 8.5 Tohoku Region
  • 8.5.1 Overview
  • 8.5.2 Historical and Current Market Trends (2020-2025)
  • 8.5.3 Market Breakup by Type
  • 8.5.4 Market Breakup by Application
  • 8.5.5 Key Players
  • 8.5.6 Market Forecast (2026-2034)
• 8.6 Chugoku Region
  • 8.6.1 Overview
  • 8.6.2 Historical and Current Market Trends (2020-2025)
  • 8.6.3 Market Breakup by Type
  • 8.6.4 Market Breakup by Application
  • 8.6.5 Key Players
  • 8.6.6 Market Forecast (2026-2034)
• 8.7 Hokkaido Region
  • 8.7.1 Overview
  • 8.7.2 Historical and Current Market Trends (2020-2025)
  • 8.7.3 Market Breakup by Type
  • 8.7.4 Market Breakup by Application
  • 8.7.5 Key Players
  • 8.7.6 Market Forecast (2026-2034)
• 8.8 Shikoku Region
  • 8.8.1 Overview
  • 8.8.2 Historical and Current Market Trends (2020-2025)
  • 8.8.3 Market Breakup by Type
  • 8.8.4 Market Breakup by Application
  • 8.8.5 Key Players
  • 8.8.6 Market Forecast (2026-2034)

9 Japan Biomaterials Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Product Portfolio
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Product Portfolio
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Product Portfolio
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Product Portfolio
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Product Portfolio
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Biomaterials Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix